Literature DB >> 23114099

Prevalence and correlates of Kaposi's sarcoma-associated herpesvirus infection in a sample of men who have sex with men in Eastern China.

T Zhang1, H Lin, V Minhas, W Zhu, C Wood, N He.   

Abstract

This study aimed to determine the seroprevalence of Kaposi’s sarcoma-associated herpesvirus(KSHV) and related factors in men who have sex with men (MSM) in China. A total of 208 subjects were recruited from eastern China from 2008 to 2009. Plasma samples were collected and screened for KSHV, HIV and syphilis. Overall, KSHV seroprevalence was 32.7% in the subjects. About 92.7% of subjects reported having ever had anal sex with a man, of whom 67.8% had receptive anal sex and 77.9% had insertive anal sex. About 93.1% of the study participants reported having had oral sex with a man, of whom 76.0% had receptive oral sex and 56.7% had insertive oral sex. KSHV seropositivity was independently associated with receptive anal sex[odds ratio (OR) 2.68, 95% confidence interval (CI) 1.15–6.23], syphilis (OR 3.25, 95% CI1.56–6.76) and HSV-2 infection (OR 2.40, 95% CI 1.09–5.26). KSHV infection is highly prevalent and is probably sexually transmitted among MSM in eastern China.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23114099      PMCID: PMC9151416          DOI: 10.1017/S0950268812002361

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  29 in total

1.  Geographic heterogeneity of prevalence of the human herpesvirus 8 in sub-Saharan Africa: clues about etiology.

Authors:  Ruth M Pfeiffer; William A Wheeler; Georgina Mbisa; Denise Whitby; James J Goedert; Guy de Thé; Sam M Mbulaiteye
Journal:  Ann Epidemiol       Date:  2010-12       Impact factor: 3.797

2.  HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE Study.

Authors:  C Casper; D Carrell; K G Miller; F D Judson; A S Meier; J S Pauk; R A Morrow; L Corey; A Wald; C Celum
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

3.  Human herpesvirus 8: serovprevalence and correlates in tumor patients from Xinjiang, China.

Authors:  Fangping He; Xing Wang; Bin He; Zongdi Feng; Xiaomei Lu; Yaoxin Zhang; Shujun Zhao; Renyong Lin; Yan Hui; Yongxing Bao; Zhaoxia Zhang; Hao Wen
Journal:  J Med Virol       Date:  2007-02       Impact factor: 2.327

4.  Risk factors for Kaposi's sarcoma among HHV-8 seropositive homosexual men with AIDS.

Authors:  Eric Nawar; Sam M Mbulaiteye; Joel E Gallant; David A Wohl; Marianne Ardini; Tabitha Hendershot; James J Goedert; Charles S Rabkin
Journal:  Int J Cancer       Date:  2005-06-10       Impact factor: 7.396

5.  The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission.

Authors:  D H Kedes; E Operskalski; M Busch; R Kohn; J Flood; D Ganem
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

Review 6.  HIV-associated lymphomas and gamma-herpesviruses.

Authors:  Antonino Carbone; Ethel Cesarman; Michele Spina; Annunziata Gloghini; Thomas F Schulz
Journal:  Blood       Date:  2008-10-27       Impact factor: 22.113

7.  Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion.

Authors:  Sara Lodi; Marguerite Guiguet; Dominique Costagliola; Martin Fisher; Andrea de Luca; Kholoud Porter
Journal:  J Natl Cancer Inst       Date:  2010-05-04       Impact factor: 13.506

8.  Sexual activity and Kaposi's sarcoma among human immunodeficiency virus type 1 and human herpesvirus type 8-coinfected men.

Authors:  Eric W Nawar; Stephen R Cole; Homayoon Farzadegan; Mallory D Witt; Frank J Jenkins; Joseph B Margolick; John P Phair; Lisa P Jacobson
Journal:  Ann Epidemiol       Date:  2008-05-27       Impact factor: 3.797

9.  Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996.

Authors:  M Melbye; P M Cook; H Hjalgrim; K Begtrup; G R Simpson; R J Biggar; P Ebbesen; T F Schulz
Journal:  Int J Cancer       Date:  1998-08-12       Impact factor: 7.396

10.  Human herpesvirus 8 seroprevalence, China.

Authors:  Tiejun Zhang; Xiaodan Shao; Yue Chen; Tao Zhang; Veenu Minhas; Charles Wood; Na He
Journal:  Emerg Infect Dis       Date:  2012-01       Impact factor: 6.883

View more
  6 in total

1.  Seroprevalence and determinants of Kaposi sarcoma-associated human herpesvirus 8 in Indian HIV-infected males.

Authors:  Arshi Munawwar; Surendra K Sharma; Somesh Gupta; Sarman Singh
Journal:  AIDS Res Hum Retroviruses       Date:  2014-12       Impact factor: 2.205

Review 2.  HIV-associated Kaposi sarcoma and related diseases.

Authors:  Priscila H Gonçalves; Thomas S Uldrick; Robert Yarchoan
Journal:  AIDS       Date:  2017-09-10       Impact factor: 4.177

3.  Palliative treatment of Kaposi sarcoma with radiotherapy: a single center experience.

Authors:  Gonca Altinisik Inan; Ipek Pinar Aral; Suheyla Aytac Arslan; Yilmaz Tezcan
Journal:  Radiat Oncol J       Date:  2021-03-22

4.  Kaposi`s sarcoma associated herpesvirus infection among female sex workers and general population women in Shanghai, China: a cross-sectional study.

Authors:  Tiejun Zhang; Ying Yang; Feng Yu; Yanping Zhao; Feifei Lin; Veenu Minhas; Charles Wood; Na He
Journal:  BMC Infect Dis       Date:  2014-02-05       Impact factor: 3.090

5.  Seroprevalence of human herpesvirus 8 and hepatitis C virus among drug users in Shanghai, China.

Authors:  Tiejun Zhang; Ying Liu; Yuyan Zhang; Jun Wang; Veenu Minhas; Charles Wood; Na He
Journal:  Viruses       Date:  2014-06-23       Impact factor: 5.048

6.  Seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus among HIV-negative people in China.

Authors:  Tiejun Zhang; Zhenqiu Liu; Jun Wang; Veenu Minhas; Charles Wood; Gary M Clifford; Na He; Silvia Franceschi
Journal:  Infect Agent Cancer       Date:  2017-05-30       Impact factor: 2.965

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.